Real-time enrollment status for this partial lipodystrophy clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 7:53 PM UTC
| NCT Number | NCT06679270 |
| Recruiting Status | Recruiting |
| Condition | Partial Lipodystrophy |
| Phase | PHASE3 |
| Target Enrollment | 24 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Amryt Pharma |
| Last Updated on CT.gov | July 16, 2026 (Jul 16, 2026) |
As of October 16, 2026: Clinical trial NCT06679270 is currently recruiting participants. This phase3 study for partial lipodystrophy is actively seeking new participants at 7 locations across the United States. The study is sponsored by Amryt Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06679270 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06679270 was last updated Jul 16, 2026 (July 16, 2026). HelloStudys verifies this status automatically.